Company / Gross Profit per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$7.99
FY2025
5-year range
$6.37 / $7.99
FY2021-FY2025
Trend
+9.9%
vs FY2024
Sector context
#9 of 29
Health Care
What the data says
At $7.99, TEVA PHARMACEUTICAL INDUSTRIES LTD's gross profit per share ranks #9 of 29 in the Health Care sector. Gross Profit per Share has increased for 3 consecutive years, from $6.37 in FY2022 to $7.99 in FY2025.
Based on SEC 10-K filings.
7.99 in FY2025 with a 5-year CAGR of +1.1%.
Improved from $6.91 to $7.99 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +7.8%
- 5-Year CAGR
- +1.1%
- 10-Year CAGR
- -
Sector benchmark
#9 of 29 in Health CareTop 31% of 29This company $7.99 Sector average $8.11
▼
-1.5% below sector average
Key checks
Key Insights
- TEVA PHARMACEUTICAL INDUSTRIES LTD's gross profit per share has grown for 3 consecutive years.
- In FY2025, gross profit per share increased 9.9% year-over-year.
- Ranks #9 out of 29 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.99 | +9.9% |
| FY2024 | $7.26 | +5.2% |
| FY2023 | $6.91 | +8.4% |
| FY2022 | $6.37 | -8.5% |
| FY2021 | $6.96 | -8.0% |
| FY2020 | $7.57 | +2.0% |
| FY2019 | $7.42 | -100.0% |
| FY2018 | $8632674.30 | +82626344.5% |
| FY2017 | $10.45 | -100.0% |
| FY2016 | $12125910.51 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026